We’re delighted to welcome Scheilly Tsilova, Ph.D to the Calla Lily Clinical Care team as our new Senior Pharmaceutical Scientist. 🥼 For the past two years, Scheilly has been instrumental in advancing our Callavid® vaginal drug delivery technology while pursuing her PhD at UCL, with a focus on polymer-based drug delivery systems.

Her deep technical expertise and hands-on experience with our technology are a superb asset as we continue our clinical development and industry engagement. In addition to her research, Scheilly brings a wealth of knowledge in formulation development and pharmaceutical testing from her time with UCL Consultants Ltd. The entire CLCC team is excited to continue with Scheilly in building an essential drug delivery platform in women’s health. 💥